Seenu Hariprasad to Diabetic Retinopathy
This is a "connection" page, showing publications Seenu Hariprasad has written about Diabetic Retinopathy.
Connection Strength
7.717
-
Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema. Expert Opin Investig Drugs. 2020 Jun; 29(6):547-554.
Score: 0.648
-
Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency. Eur J Ophthalmol. 2021 Mar; 31(2):612-619.
Score: 0.634
-
Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure. Indian J Ophthalmol. 2016 Sep; 64(9):643-647.
Score: 0.502
-
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):308-12.
Score: 0.487
-
Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar; 46(3):302-5.
Score: 0.452
-
Optimal area of retinal photocoagulation necessary for suppressing active iris neovascularization associated with diabetic retinopathy. Int Ophthalmol. 2015 Apr; 35(2):155-6.
Score: 0.448
-
Ultra-widefield retinal imaging in the management of diabetic eye diseases. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct; 45(5):363-6.
Score: 0.437
-
The evolving paradigm for the treatment of diabetic macular edema. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):324-8.
Score: 0.403
-
Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema. Am J Ophthalmol. 2013 Jun; 155(6):1038-1044.e2.
Score: 0.393
-
Cystoid and diabetic macular edema treated with nepafenac 0.1%. J Ocul Pharmacol Ther. 2007 Dec; 23(6):585-90.
Score: 0.274
-
Vision-related quality of life in patients with diabetic macular oedema. Br J Ophthalmol. 2008 Jan; 92(1):89-92.
Score: 0.265
-
ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT. Retina. 2024 02 01; 44(2):205-213.
Score: 0.210
-
Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study. Invest Ophthalmol Vis Sci. 2023 08 01; 64(11):22.
Score: 0.203
-
The Next-Generation Diagnostic and Therapeutic Algorithms for Diabetic Macular Edema Using Artificial Intelligence. Ophthalmic Surg Lasers Imaging Retina. 2023 04; 54(4):201-204.
Score: 0.198
-
Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration From Major Studies and Real-World Data. Asia Pac J Ophthalmol (Phila). 2023 Mar-Apr 01; 12(2):168-183.
Score: 0.198
-
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Ophthalmic Surg Lasers Imaging Retina. 2023 03; 54(3):166-173.
Score: 0.197
-
Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2. Int J Mol Sci. 2022 Jul 16; 23(14).
Score: 0.188
-
Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature. Exp Biol Med (Maywood). 2022 02; 247(4):317-329.
Score: 0.182
-
Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein Angiography. Am J Ophthalmol. 2021 04; 224:292-300.
Score: 0.169
-
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders. Acta Diabetol. 2019 Jun; 56(6):675-680.
Score: 0.149
-
Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2019 01 01; 50(1):4-7.
Score: 0.147
-
Rethinking Management Strategies for Proliferative Diabetic Retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2018 04 01; 49(4):224-227.
Score: 0.140
-
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017 Dec; 184:121-128.
Score: 0.136
-
Role of Disorganization of Retinal Inner Layers as an Optical Coherence Tomography Biomarker in Diabetic and Uveitic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2017 04 01; 48(4):282-288.
Score: 0.131
-
Treatments for Diabetic Macular Edema: Past, Present, and Future. Ophthalmic Surg Lasers Imaging Retina. 2016 09 01; 47(9):794-800.
Score: 0.125
-
Surgical management of proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun; 45(3):188-93.
Score: 0.107
-
ILM peeling a vital intervention for many vitreoretinal disorders. Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr; 45(2):92-6.
Score: 0.105
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012 Oct; 119(10):2125-32.
Score: 0.094
-
The utility of visual function questionnaire in the assessment of the impact of diabetic retinopathy on vision-related quality of life. Eye (Lond). 2010 Jan; 24(1):29-35.
Score: 0.075
-
Bacterial contamination of needles used for intravitreal injections: a prospective, multicenter study. Ocul Immunol Inflamm. 2011 Feb; 19(1):32-8.
Score: 0.021